Colchester’s Vernal Biosciences Raises $20 Million to Expand
Vernal Biosciences has received $21 million from investors and is expanding to a new laboratory in Essex next year.
Vernal Biosciences
Burlington tech startup raises millions to accelerate manufacturing growth
Vernal Biosciences has raised $21 million to build a manufacturing facility in Essex that will scale up the business from supporting research to being involved in clinical trials.
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions.
Vernal welcomes Scott Vanson and JJ Bivona to the team
We are excited to announce the addition of two new members to the Vernal team: Scott Vanson, Ph.D. and JJ Bivona, Ph.D.
Vernal Biosciences awarded nearly $100k in Vermont Training Grant
Vernal Biosciences has been awarded a $99,475 grant from the Vermont Training Program (VTP).
Vernal Biosciences launches preclinical LNP formulation service with biodistribution results
We recently completed a biodistribution study of lipid nanoparticles containing mRNA encoding luciferase in mice.
Colchester mRNA lab putting local college grads to work
Vernal Biosciences in Colchester helps make mRNA, which acts as a kind of roadmap a cell uses to make a specific protein.
Colchester’s Vernal Biosciences Manufactures the mRNA That’s Revolutionizing Medicine
Five years ago, when Christian Cobaugh had the idea of starting a biotech company to manufacture mRNA, the genetic term wasn't in the vernacular of most nonscientists.
Vernal Biosciences Launches to Democratize Access to High Quality mRNA Manufacturing
We announced the closing of a seed round of financing today.